Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Speech Motor Learning and Retention (Aim 3)

NCT: NCT06492252 · RECRUITING

NCT IDNCT06492252
StatusRECRUITING
Start Date2026-05-04
Completion2029-05-31

Brief Summary

The overall goal of this research is to test a new model of speech motor learning, whose central hypothesis is that learning and retention are associated with plasticity not only in motor areas of the brain but in auditory and somatosensory regions as well. The strategy for the proposed research is to identify individual brain areas that contribute causally to retention by disrupting their activity with transcranial magnetic stimulation (TMS). Investigators will also use functional magnetic resonance imaging (fMRI) which will enable identification of circuit-level activity which predicts either learning or retention of new movements, and hence test the specific contributions of candidate sensory and motor zones. In other studies, investigators will record sensory and motor evoked potentials over the course of learning to determine the temporal order in which individual sensory and cortical motor regions contribute. The goal here is to identify brain areas in which learning-related plasticity occurs first and which among these areas predict subsequent learning.

Frequently Asked Questions

What is Speech Motor Learning and Retention (Aim 3)?

Speech Motor Learning and Retention (Aim 3) is a clinical trial registered under NCT06492252. Current status: RECRUITING.

What is the status of NCT06492252?

The current status of NCT06492252 (Speech Motor Learning and Retention (Aim 3)) is: RECRUITING.

When did Speech Motor Learning and Retention (Aim 3) start?

Speech Motor Learning and Retention (Aim 3) started on 2026-05-04.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.